Abstract
Marfan syndrome is associated with significant cardiovascular morbidity and mortality. This chapter discusses the presentation, diagnosis and treatment of cardiovascular disease in the child with Marfan syndrome and highlights pitfalls in diagnosis and controversies in management.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Marfan AB. Un cas de deformation congenitale des quatre membres, plus prononce aux extremetes, characterise par l’allongement des os avec un certain degre d’amincissement. Bull Mem Soc Hop (Paris). 1896;13:220–6.
Loeys BL, et al. The revised Ghent nosology for the Marfan syndrome. J Med Genet. 2010;47(7):476–85.
Geva T, et al. Two-dimensional and Doppler echocardiographic and pathologic characteristics of the infantile Marfan syndrome. Am J Cardiol. 1990;65(18):1230–7.
Lopes LM, et al. Echocardiographic diagnosis of fetal Marfan syndrome at 34 weeks’ gestation. Prenat Diagn. 1995;15(2):183–5.
Morse RP, et al. Diagnosis and management of infantile Marfan syndrome. Pediatrics. 1990;86(6):888–95.
Geva T, Hegesh J, Frand M. The clinical course and echocardiographic features of Marfan’s syndrome in childhood. Am J Dis Child. 1987;141(11):1179–82.
Stheneur C, et al. Study of phenotype evolution during childhood in Marfan syndrome to improve clinical recognition. Genet Med. 2014;16(3):246–50.
Faivre L, et al. Clinical and molecular study of 320 children with Marfan syndrome and related type I fibrillinopathies in a series of 1009 probands with pathogenic FBN1 mutations. Pediatrics. 2009;123(1):391–8.
Stuart AG. The paediatric cardiologist and Marfan syndrome. In: Child AH, Briggs MJ, editors. The Marfan syndrome. A clinical guide. London: British Heart Foundation; 2002. p. 16–23.
Phornphutkul C, Rosenthal A, Nadas AS. Cardiac manifestations of Marfan syndrome in infancy and childhood. Circulation. 1973;47(3):587–96.
el Habbal MH. Cardiovascular manifestations of Marfan’s syndrome in the young. Am Heart J. 1992;123(3):752–7.
Stuart AG, Davies S. Welsh paediatric surveillance system report: Marfan syndrome. Cardiff: Welsh Office; 1997.
Stuart AG, Williams A. Marfan’s syndrome and the heart. Arch Dis Child. 2007;92(4):351–6.
Chen S, et al. Ventricular dysrhythmias in children with Marfan’s syndrome. Am J Dis Child. 1985;139(3):273–6.
Adams JN, et al. Aortic distensibility and stiffness index measured by magnetic resonance imaging in patients with Marfan’s syndrome. Br Heart J. 1995;73(3):265–9.
Hirata K, et al. The Marfan syndrome: abnormal aortic elastic properties. J Am Coll Cardiol. 1991;18(1):57–63.
Wilson DG, et al. Endothelial function in Marfan syndrome: selective impairment of flow-mediated vasodilation. Circulation. 1999;99(7):909–15.
Keane MG, Pyeritz RE. Medical management of Marfan syndrome. Circulation. 2008;117(21):2802–13.
Tinkle BT, Saal HM, Committee on Genetics. Health supervision for children with Marfan syndrome. Pediatrics. 2013;132(4):e1059–72.
Das BB, Taylor AL, Yetman AT. Left ventricular diastolic dysfunction in children and young adults with Marfan syndrome. Pediatr Cardiol. 2006;27(2):256–8.
Roman MJ, et al. Two-dimensional echocardiographic aortic root dimensions in normal children and adults. Am J Cardiol. 1989;64(8):507–12.
Wilson DG, et al. Electrocardiographic abnormalities in the child with Marfan syndrome. Eur J Paediatr. 1996;155:730.
Shores J, et al. Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan’s syndrome. N Engl J Med. 1994;330(19):1335–41.
Williams A, et al. Medical treatment of Marfan syndrome: a time for change. Heart. 2008;94(4):414–21.
Loeys BL. Angiotensin receptor blockers: a panacea for Marfan syndrome and related disorders? Drug Discov Today. 2015;20(2):262–6.
Brooke BS, et al. Angiotensin II blockade and aortic-root dilation in Marfan’s syndrome. N Engl J Med. 2008;358(26):2787–95.
Pees C, et al. Usefulness of losartan on the size of the ascending aorta in an unselected cohort of children, adolescents, and young adults with Marfan syndrome. Am J Cardiol. 2013;112(9):1477–83.
Lacro RV, Dietz HC, Mahony L. Atenolol versus Losartan in Marfan’s syndrome. N Engl J Med. 2015;372(10):980–1.
Patel ND, et al. Valve-sparing aortic root replacement in children: intermediate-term results. Interact Cardiovasc Thorac Surg. 2011;12(3):415–9; discussion 419.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer-Verlag London
About this chapter
Cite this chapter
Stuart, G. (2016). The Child with Marfan Syndrome: A Paediatric Cardiology Approach. In: Child, A. (eds) Diagnosis and Management of Marfan Syndrome. Springer, London. https://doi.org/10.1007/978-1-4471-5442-6_5
Download citation
DOI: https://doi.org/10.1007/978-1-4471-5442-6_5
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-5441-9
Online ISBN: 978-1-4471-5442-6
eBook Packages: MedicineMedicine (R0)